Promotions & Moves
Related Searches:
Filter by:
451 - 465 of 1172 results
December 15, 2010
Ian Read, Pfizer’s new chief executive officer, has made changes to the company’s executive team.
Read More »
December 14, 2010
Kathleen P. Bloch has been appointed chief financial officer of Laureate Pharma.
Read More »
December 9, 2010
Catalent Pharma Solutions has appointed Scott Neilson as vice president of Operations Development, Elaine Dymond as vice president of Quality, Ronald Overhiser as vice president of Innovation Operations, and Evjatar Cohen as vice president of Portfolio Ma
Read More »
December 9, 2010
Scott Knorr has been appointed vice president and general manager of Adhesives Research, Inc.’s Adhesives Research division.
Read More »
December 9, 2010
Howard Moody has been appointed chief information officer and Alan Findlater has been appointed chief commercial officer of WIL Research Co.
Read More »
December 8, 2010
John G. Figueroa has been appointed chief executive officer of Omnicare, Inc., effective January 1, 2011.
Read More »
December 7, 2010
David A. Gelber has been appointed vice president of operations at Coldstream Laboratories, Inc.
Read More »
December 7, 2010
Robert L. Roy, PE, senior consultant; Jason S. Collins, RA, NCARB, senior process architect; and Louis Isernia, project manager, have joined Integrated Project Services’ Advanced Aseptic Technologies Group.
Read More »
December 6, 2010
Ian C. Read succeeds Jeffrey B. Kindler as Pfizer's president and chief executive officer.
Read More »
December 3, 2010
Elena Logan has been appointed senior vice president of global central labs at PPD, Inc.
Read More »
December 3, 2010
BASi (Bioanalytical Systems Inc.) has added three representatives to its business development team.
Read More »
December 3, 2010
HemaQuest Pharmaceuticals, Inc. has added three executives to its management team.
Read More »
December 1, 2010
Wesley P. Wheeler, chief executive officer and president of Patheon has left the company.
Read More »
November 30, 2010
Chris Beaver, Ph.D. has been appointed director of Immunochemistry Services at PharmaNet Development Group.
Read More »
November 30, 2010
Kenneth C. Frazier, currently president of Merck, has been appointed chief executive officer and president of the company, as well as a member of the board, effective January 1, 2011.
Read More »
451 - 465 of 1172 results
